Adams Diversified Equity Fund’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-91,200	Closed	-$13.9M	–	117
2021 Q1	$13.9M	Hold	91,200	–	–	0.6%	62
2020 Q4	$14.2M	Hold	91,200	–	–	0.64%	59
2020 Q3	$10.4M	Hold	91,200	–	–	0.51%	74
2020 Q2	$10.2M	Buy	+91,200	New	+$9.68M	0.54%	69
2019 Q3	–	Sell	-146,700	Closed	-$19.2M	–	215
2019 Q2	$19.2M	Hold	146,700	–	–	1.02%	36
2019 Q1	$19.8M	Buy	146,700 +39,500	+37%	+$4.91M	1.09%	30
2018 Q4	$10.4M	Hold	107,200	–	–	0.64%	64
2018 Q3	$14.9M	Hold	107,200	–	–	0.74%	54
2018 Q2	$13.3M	Hold	107,200	–	–	0.71%	57
2018 Q1	$11.9M	Buy	107,200 +33,800	+46%	+$4.04M	0.65%	61
2017 Q4	$8.78M	Hold	73,400	–	–	0.47%	76
2017 Q3	$10.3M	Buy	+73,400	New	+$9.97M	0.56%	71